Clinical Trials Sponsored by Spectral Diagnostics (US) Inc.

Total 5 results

Spectral Diagnostics (US) Inc.

Recruiting

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study (TIGRIS)

Septic Shock | Endotoxemia

United States
Spectral Diagnostics (US) Inc.

No longer available

Evaluating the Use of Polymyxin B Cartridge Hemoperfusion for Patients With Septic Shock and COVID 19

Septic Shock | Endotoxemia | COVID | Corona Virus Infection | Sepsis, Severe

United States
Spectral Diagnostics (US) Inc.

Temporarily not available

Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock (EUPHORIA)

Septic Shock | Endotoxemia
Spectral Diagnostics (US) Inc.

Completed

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock (EUPHRATES)

Septic Shock | Endotoxemia

United States, Canada
Foundation for Innovative New Diagnostics, Switzerland
Indian Council of Medical Research; University of Oxford; WHO, Special Programme...

Completed

Advancing Access to Diagnostic Innovation Essential for UHC and AMR Prevention (Accelerator)

Acute Febrile Illness

Uganda, Burkina Faso, Ghana, India, Nepal

3

Subscribe